Autoimmune Thyroid Diseases

References
1 Rapoport B, McLachlan SM. Reflections on thyroid autoimmunity: a personal overview from the past into the future. Horm Metab Res 2018; 50: 840-852
2 Diana T, Olivo PD, Kahaly GJ. Thyrotropin receptor blocking antibodies. Horm Metab Res 2018; 50: 853-862
3 Pujol-Borrell R, Álvarez-Sierra D, Jaraquemada D, Marín-Sánchez A, Colobran R. Central tolerance mechanisms to TSHR in Graves’ disease: contributions to understand the genetic association. Horm Metab Res 2018; 50: 863-870
4 Kotwal A, Stan M. Current and future treatments for Graves’ disease and Graves’ ophthalmopathy. Horm Metab Res 2018; 50: 871-886
5 Marinò M, Dottore GR, Leo M, Marcocci C. Mechanistic pathways of selenium in the treatment of Graves’ disease and Graves’ orbitopathy. Horm Metab Res 2018; 50: 887-893
6 Krause G, Marcinkowski P. Intervention strategies into glycoprotein hormone receptors for modulating (mal-)function, with special emphasis on the TSH receptor. Horm Metab Res 2018; 50: 894-907
7 Williams DE, Le SN, Godlewska M, Hoke DE, Buckle AM. Thyroid peroxidase as an autoantigen in Hashimoto’s disease: structure, function, and antigenicity. Horm Metab Res 2018; 50: 908-921
8 Nagayama Y. Thyroid autoimmunity and thyroid cancer – the pathogenic connection: a 2018 update. Horm Metab Res 2018; 50: 922-931
9 Moshkelgosha S, Masetti G, Berchner-Pfannschmidt U, Verhasselt HL, Horstmann M, Diaz-Cano S, Noble A, Edelman B, Covelli D, Plummer S, Marchesi JR, Ludgate M, Biscarini F, Eckstein A, Banga JP. Gut microbiome in BALB/c and C57BL/6J mice undergoing experimental thyroid autoimmunity associate with differences in immunological responses and thyroid function. Horm Metab Res 2018; 50: 932-941
10 Hargreaves CE, Grasso M, Hampe CS, Stenkova A, Atkinson S, Joshua GW, Wren BW, Buckle AM, Dunn-Walters D, Banga JP. Yersinia enterocolitica provides the link between thyroid-stimulating antibodies and their germline counterparts in Graves’ disease. J Immunol 2013; 190: 5373-5381